Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diarmuid Smith

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Irish Journal of Medical Science|August 18, 2020
The diagnostic utility of late night salivary cortisol (LNSF) and cortisone (LNSE) in Cushing's syndromeAoife Garrahy, Hannah Forde, Patrick O'Kelly, et al.
BMC Endocrine Disorders|August 4, 2016
Utility of repeat cytological assessment of thyroid nodules initially classified as benign: clinical insights from multidisciplinary care in an Irish tertiary referral centreNigel Glynn, Mark J Hannon, Sarah Lewis, et al.
Thrombosis Research|October 12, 2010
Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic statusEoin P O'Sullivan, David T Ashley, Colin Davenport, et al.
Clinical Endocrinology|November 4, 2016
The effect of growth hormone replacement on the thyroid axis in patients with hypopituitarism: in vivo and ex vivo studiesNigel Glynn, Helena Kenny, Leah Quisenberry, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 10, 2023
Diagnosis and treatment of anti-insulin antibody-mediated labile glycaemia in insulin-treated diabetesDavid S Church, Peter Barker, Keith A Burling, et al.
BMC Endocrine Disorders|October 10, 2020
The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapyRosemary Dineen, Lucy-Ann Behan, Grainne Kelleher, et al.
BMC Endocrine Disorders|April 16, 2022
Is repeat fine needle aspiration required in thyroid nodules with initial benign cytology? Results from a large Irish seriesHafiz M Zia-Ul-Hussnain, Oratile Kgosidialwa, Carmel Kennedy, et al.
European Journal of Endocrinology|January 29, 2021
Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over studyRosemary Dineen, Julie Martin-Grace, Khalid Mohamed Saeed Ahmed, et al.
Cancers|April 3, 2021
Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"Niamh M Keegan, Simon J Furney, Janice M Walshe, et al.
The Journal of Clinical Endocrinology and Metabolism|June 20, 2023
Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone TherapyRosemary A Dineen, Julie Martin-Grace, Khalid Mohamed Saeed Ahmed, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Irish Journal of Medical Science|August 18, 2020
The diagnostic utility of late night salivary cortisol (LNSF) and cortisone (LNSE) in Cushing's syndromeAoife Garrahy, Hannah Forde, Patrick O'Kelly, et al.
BMC Endocrine Disorders|August 4, 2016
Utility of repeat cytological assessment of thyroid nodules initially classified as benign: clinical insights from multidisciplinary care in an Irish tertiary referral centreNigel Glynn, Mark J Hannon, Sarah Lewis, et al.
Thrombosis Research|October 12, 2010
Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic statusEoin P O'Sullivan, David T Ashley, Colin Davenport, et al.
Clinical Endocrinology|November 4, 2016
The effect of growth hormone replacement on the thyroid axis in patients with hypopituitarism: in vivo and ex vivo studiesNigel Glynn, Helena Kenny, Leah Quisenberry, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 10, 2023
Diagnosis and treatment of anti-insulin antibody-mediated labile glycaemia in insulin-treated diabetesDavid S Church, Peter Barker, Keith A Burling, et al.
BMC Endocrine Disorders|October 10, 2020
The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapyRosemary Dineen, Lucy-Ann Behan, Grainne Kelleher, et al.
BMC Endocrine Disorders|April 16, 2022
Is repeat fine needle aspiration required in thyroid nodules with initial benign cytology? Results from a large Irish seriesHafiz M Zia-Ul-Hussnain, Oratile Kgosidialwa, Carmel Kennedy, et al.
European Journal of Endocrinology|January 29, 2021
Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over studyRosemary Dineen, Julie Martin-Grace, Khalid Mohamed Saeed Ahmed, et al.
Cancers|April 3, 2021
Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"Niamh M Keegan, Simon J Furney, Janice M Walshe, et al.
The Journal of Clinical Endocrinology and Metabolism|June 20, 2023
Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone TherapyRosemary A Dineen, Julie Martin-Grace, Khalid Mohamed Saeed Ahmed, et al.
Pageof 8